Zacks Industry Outlook Philip Morris, Altria and British American Tobacco

20.05.24 12:09 Uhr

Werte in diesem Artikel
Aktien

42,85 EUR 1,31 EUR 3,15%

29,40 EUR 0,37 EUR 1,27%

92,58 EUR -1,52 EUR -1,62%

Indizes

PKT PKT

8.237,7 PKT -34,7 PKT -0,42%

4.490,9 PKT -17,5 PKT -0,39%

1.732,1 PKT 1,8 PKT 0,11%

15.371,9 PKT 84,4 PKT 0,55%

2.642,5 PKT -6,0 PKT -0,23%

5.464,6 PKT -8,6 PKT -0,16%

4.513,3 PKT -31,4 PKT -0,69%

For Immediate ReleaseChicago, IL – May 20, 2024 – Today, Zacks Equity Research Philip Morris International Inc. PM, Altria Group, Inc. MO and British American Tobacco p.l.c. BTIIndustry: TobaccoLink: https://www.zacks.com/commentary/2275240/3-tobacco-stocks-worth-watching-amid-industry-challengesThe Zacks Tobacco industry players have been witnessing soft cigarette sales volumes due to inflation, changing consumer habits, and stringent regulations. Increased costs of essential materials further raise concerns for profit margins.While investments in smoke-free products come at the cost of margins, they have been driving revenues of tobacco companies, given consumers’ growing health consciousness. Pricing power has also been working well. These upsides keep Philip Morris International Inc. , Altria Group, Inc. and British American Tobacco p.l.c. well positioned despite the industry challenges.About the IndustryThe Zacks Tobacco industry includes companies that manufacture and sell cigarettes as well as tobacco and nicotine-based products, such as cigars, snuffs and oral tobacco. Some companies also offer RRPs, such as e-cigarettes, vaping and heat-not-burn variants. A few of the firms are engaged in making devices and attachments needed in vaping and heat-not-burn products.Most products manufactured by the tobacco industry participants fall under the strict vigilance of the U.S. Food and Drug Administration (“FDA”) and are required to follow the permissible levels of nicotine in manufacturing. Players in this space sell products mostly through large retailers, distributors, convenience stores, drugstores, wholesalers and grocery chains. Additionally, some international tobacco firms operate in the country through subsidiaries.4 Trends Shaping the Future of the Tobacco IndustryCigarette Volumes Under Pressure: The tobacco industry is grappling with challenges related to the inflationary environment, which has significantly influenced consumer spending habits. Economic factors such as inflation, increased interest rates, and Adult Tobacco Consumers’ dynamics, including changing purchasing patterns, the adoption of smoke-free products, and shifts in disposable income, have affected cigarette sales volumes.Additionally, stringent government regulations on sales, marketing, and manufacturing, prompted by the health hazards of nicotine consumption, have further impacted volumes. Some guidelines issued by the FDA include the mandatory use of precautionary labels on cigarette packets and self-critical advertisements. As cigarette sales constitute a significant portion of revenues for tobacco industry companies, the decrease in sales volumes within this category raises concerns.Escalated Costs: Numerous industry participants have been affected by cost inflation. Global inflationary challenges linked to essential materials such as tobacco leaf, energy and labor costs have been concerns. Elevated expenses related to the research, development and marketplace activities of smoke-free products further present risks to profit margins.Growing Popularity of Smoke-Free Alternatives: Increasing awareness of health risks and stringent government regulations intended to curtail cigarette smoking have encouraged many consumers to switch to reduced-risk products (RRPs) or smoke-free alternatives. Promoted as having a less adverse impact on health due to their scientific composition and method of consumption, these products are gaining popularity.More consumers are turning to these alternatives as a way to quit smoking traditional cigarettes. Major players in the tobacco industry have been allocating resources to expand their presence in this category, including investing in innovations to make these products more user-friendly and energy-efficient. Companies have been experiencing significant revenue growth in the RRP or smoke-free product space.Philip Morris and British American Tobacco have been proactively working toward transitioning into predominantly smoke-free companies in the coming years. The continued popularity and resilience of these products are expected to drive positive outcomes for industry players amid ongoing business transformations.Pricing Power: Players in the tobacco industry have been leveraging the strong pricing influence of tobacco products, which also helps them make up for high taxes and soft cigarette sales volumes. Since smokers tend to be less responsive to price hikes due to their addiction, this approach is anticipated to continue benefiting companies within the tobacco sector. The prudent pricing of cigarettes has been supporting the revenues of players in the tobacco industry in the face of declining volumes.Zacks Industry Rank Indicates Dull ProspectsThe Zacks Tobacco industry is housed within the broader Zacks Consumer Staples sector. The industry currently carries a Zacks Industry Rank #174, which places it in the bottom 30% of more than 250 Zacks industries.The group’s Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates drab near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.The industry’s position in the bottom 50% of the Zacks-ranked industries is a result of a positive earnings outlook for the constituent companies in aggregate. Looking at the aggregate earnings estimate revisions, it appears that analysts are gradually losing confidence in this group’s earnings growth potential. Since the beginning of February 2024, the industry’s earnings estimate for 2024 has declined 2.2%.Let’s take a look at the industry’s performance and current valuation.Industry vs. Broader MarketThe Zacks Tobacco industry has underperformed the Zacks S&P 500 Composite, while outperforming the broader Zacks Consumer Staple sector over the past year.The industry has gained 4.1% over this period against the broader sector’s drop of 5.3%. Meanwhile, the S&P 500 has risen 27.7% in the said time frame.Industry's Current ValuationOn the basis of forward 12-month price-to-earnings (P/E), which is commonly used for valuing consumer staple stocks, the industry is currently trading at 10.24X compared with the S&P 500’s 21.21X and the sector’s 17.34X.Over the past five years, the industry has traded as high as 12.68X, as low as 9.1X and at the median of 10.67X.3 Tobacco Stocks to Keep a Close Eye OnPhilip Morris International: The Zacks Rank #3 (Hold) company’s emphasis on smoke-free products, aligned with evolving consumer preferences, has strengthened its market position. Philip Morris is progressing toward its objective of becoming a predominantly smoke-free company by 2030. The exceptional performance of its premium smoke-free brands, IQOS and ZYN, is driving the success of its smoke-free product portfolio. Additionally, this tobacco giant has been positively impacted by its strong pricing strategies. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.The Zacks Consensus Estimate for PM’s 2024 earnings per share (EPS) has declined to $6.31 from $6.37 in the past 30 days. However, the consensus mark suggests growth of almost 5% from the year-ago period figure. Shares of Philip Morris have risen 9% in the past six months.Altria Group: The Zacks Rank #3 company has demonstrated resilience in a challenging environment by leveraging its pricing power and prioritizing smoke-free alternatives. Altria’s investment in on! has been particularly effective in the oral tobacco realm. Additionally, the acquisition of NJOY Holdings represents a major advancement in the e-vapor category. Some of MO’s 2028 Enterprise Goals include doubling its U.S. smoke-free net revenues to $5 billion from its 2022 level and driving mid-single-digit adjusted EPS growth through 2028 on a compounded annual basis.Altria shares have rallied 12.5% in the past six months. The Zacks Consensus Estimate for MO’s 2024 EPS has risen by 2 cents to $5.11 over the past 30 days.British American Tobacco: BTI's strategic focus on growth, innovation, and market leadership in the evolving tobacco and nicotine product landscape has been working well. The company has been benefiting from its efforts to strengthen the Heated Products portfolio with innovative launches like glo Hyper pro and expanding tobacco-free consumables.Additionally, the Zacks Rank #3 company has been enhancing its innovation pipeline by strengthening R&D capabilities, adding device engineering, and forming a collaborative global network. That said, British American Tobacco’s efforts to return the U.S. combustibles business to consistent value growth bode well.The Zacks Consensus Estimate for British American Tobacco’s 2024 bottom line has declined 0.4% to $4.68 over the past 30 days. Shares of BTI have lost 0.5% in the past six months.Why Haven’t You Looked at Zacks' Top Stocks?Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.Today you can access their live picks without cost or obligation.See Stocks Free >>Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch/Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.Media ContactZacks Investment Research800-767-3771 ext. 9339support@zacks.comhttps://www.zacks.comPast performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance  for information about the performance numbers displayed in this press release.Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Altria Group, Inc. (MO): Free Stock Analysis Report Philip Morris International Inc. (PM): Free Stock Analysis Report British American Tobacco p.l.c. (BTI): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Altria

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Altria

NameHebelKOEmittent
NameHebelKOEmittent
Werbung

Quelle: Zacks

Nachrichten zu BAT PLC (British American Tobacco)

Analysen zu BAT PLC (British American Tobacco)

DatumRatingAnalyst
11.06.2024BAT BuyDeutsche Bank AG
05.06.2024BAT NeutralUBS AG
05.06.2024BAT NeutralJP Morgan Chase & Co.
05.06.2024BAT NeutralGoldman Sachs Group Inc.
04.06.2024BAT NeutralGoldman Sachs Group Inc.
DatumRatingAnalyst
11.06.2024BAT BuyDeutsche Bank AG
04.06.2024BAT BuyJefferies & Company Inc.
30.05.2024BAT BuyJefferies & Company Inc.
21.05.2024BAT BuyDeutsche Bank AG
22.04.2024BAT BuyJefferies & Company Inc.
DatumRatingAnalyst
05.06.2024BAT NeutralUBS AG
05.06.2024BAT NeutralJP Morgan Chase & Co.
05.06.2024BAT NeutralGoldman Sachs Group Inc.
04.06.2024BAT NeutralGoldman Sachs Group Inc.
04.06.2024BAT NeutralJP Morgan Chase & Co.
DatumRatingAnalyst
21.11.2019BAT UnderweightMorgan Stanley
21.10.2019BAT UnderperformMerrill Lynch & Co., Inc.
17.06.2019BAT UnderweightMorgan Stanley
16.10.2018BAT UnderperformRBC Capital Markets
15.10.2018BAT UnderperformRBC Capital Markets

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für BAT PLC (British American Tobacco) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"